Log in | Register

Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 23, Issue 4

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Drug Safety, Volume 23, Issue 4 (2024)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 23, Issue 4 (2024)

See all volumes and issues

Volume 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Disparities in drug safety practices in developing nations: focusing on underlying factors and implications for global health

Ahmad Z. Al Meslamani, Derar H. Abdel-Qader, Amira B. Kassem & Nadia Al Mazrouei

Pages: 393-397

Published online: 07 Mar 2024

First Page PreviewforDisparities in drug safety practices in developing nations: focusing on underlying factors and implications for global health | Full Text | References | PDF (201 KB) | EPUB

289 Views
0 CrossRef citations
0Altmetric

Free Access

Review

Review Article

Tolerability and safety outcomes of first-line oral second-generation antipsychotics in patients with schizophrenia

Kristen Ward & Leslie Citrome

Pages: 399-409

Published online: 25 Mar 2024

AbstractforTolerability and safety outcomes of first-line oral second-generation antipsychotics in patients with schizophrenia | Full Text | References | PDF (457.6 KB) | EPUB

147 Views
0 CrossRef citations
0Altmetric

Review Article

A safety review of tyrosine kinase inhibitors for chronic myeloid leukemia

Deniz Özmen, Duygu Demet Alpaydın, Muhammed Ali Saldoğan & Ahmet Emre Eşkazan

Pages: 411-423

Published online: 01 Apr 2024

AbstractforA safety review of tyrosine kinase inhibitors for chronic myeloid leukemia | Full Text | References | PDF (398.3 KB) | EPUB

78 Views
0 CrossRef citations
0Altmetric

Review Article

Chemical-induced liver cancer: an adverse outcome pathway perspective

Julen Sanz-Serrano, Ellen Callewaert, Sybren De Boever, Annika Drees, Anouk Verhoeven & Mathieu Vinken

Pages: 425-438

Published online: 13 Mar 2024

AbstractforChemical-induced liver cancer: an adverse outcome pathway perspective | Full Text | References | PDF (4.3 MB) | EPUB

116 Views
0 CrossRef citations
0Altmetric

Review Article

Dupilumab in real-life settings: a review of adverse events and their pathogenesis

Elisa Camela, Anna Rita Giampetruzzi, Ornella De Pità, Sabatino Pallotta & Filomena Russo

Pages: 439-447

Published online: 12 Mar 2024

AbstractforDupilumab in real-life settings: a review of adverse events and their pathogenesis | Full Text | References | PDF (305.7 KB) | EPUB

796 Views
0 CrossRef citations
0Altmetric

Open Access

Original Research

Article

Ustekinumab as induction and maintenance therapy for ulcerative colitis – national extended follow-up and a review of the literature

JD. Chetwood, S. Gupta, K. Subramaniam, P. De Cruz, G. Moore, YK. An, SJ. Connor, M. Kermeen, S. Paramsothy & RW. Leong

Pages: 449-456

Published online: 10 Nov 2023

173 Views
1 CrossRef citations
0Altmetric

Article

Renal drug dosage adjustments and adverse drug events in patients with chronic kidney disease admitted to the hospital: a cross-sectional study

Zuzana Očovská, Jana Procházková, Martina Maříková & Jiří Vlček

Pages: 457-467

Published online: 08 Feb 2024

957 Views
0 CrossRef citations
0Altmetric

Open Access

Article

T-wave morphology abnormalities in the STREAM stage 1 trial

Gareth Hughes, William J. Young, Henry Bern, Angela Crook, Pier D. Lambiase, Ruth L. Goodall, Andrew J. Nunn & Sarah K. Meredith

Pages: 469-476

Published online: 10 Mar 2024

AbstractforT-wave morphology abnormalities in the STREAM stage 1 trial | Full Text | References | PDF (793.3 KB) | EPUB

228 Views
0 CrossRef citations
0Altmetric

Open Access

Article

A comprehensive analysis of liver safety across zibotentan oncology trials: knowledge of the past offers new perspectives on the present

Anna Fettiplace, Sherri Matis-Mitchell, Oleksandr Molodetskyi, Malin Söderbergh, Jan Oscarsson, Min Lin, Srivathsa Ravikiran, Martin Billger & Philip Ambery

Pages: 477-486

Published online: 24 Mar 2024

386 Views
0 CrossRef citations
0Altmetric

Open Access

Article

Hemorrhage induced by antithrombotic agents: new insights from a real-world pharmacovigilance study

Kangyuan Guo, Ganyi Wang, Li Zhang, Zhanchun Feng, Xudong Xia, Xiaobo Sun, Ziqi Yan, Zhiming Jiao & Da Feng

Pages: 487-495

Published online: 18 Mar 2024

AbstractforHemorrhage induced by antithrombotic agents: new insights from a real-world pharmacovigilance study | Full Text | References | PDF (824.3 KB) | EPUB

62 Views
0 CrossRef citations
0Altmetric

Article

Hemorrhage profile associated with immune checkpoint inhibitors: a systematic review and a real-world study based on the FAERS database

Mengting Chen, Zhichao He, Jianhong Zhu, Shan Yang, Siyuan Gao, Jie Wu, Huaying Ren, Dan Liang, Wei Jiang, Ying Zou, Xiaoxia Yu & Junyan Wu

Pages: 497-511

Published online: 31 Mar 2024

64 Views
0 CrossRef citations
0Altmetric

Article

Data mining and safety analysis of traditional immunosuppressive drugs: a pharmacovigilance investigation based on the FAERS database

Juan-Juan Li, Li Chen, Yang Zhao, Xue-Qin Yang, Fa-Bin Hu & Li Wang

Pages: 513-525

Published online: 27 Mar 2024

AbstractforData mining and safety analysis of traditional immunosuppressive drugs: a pharmacovigilance investigation based on the FAERS database | Full Text | References | PDF (2.7 MB) | EPUB

106 Views
0 CrossRef citations
0Altmetric

Article

Liver toxicity in oncology trials and beyond: a simplified concept for management of hepatocellular drug-induced liver injury in patients with abnormal baseline liver tests

Michael Merz, Anna Fettiplace, John Marcinak, Hans L. Tillmann, Don C. Rockey & Gerd A. Kullak-Ublick

Pages: 527-537

Published online: 04 Apr 2024

AbstractforLiver toxicity in oncology trials and beyond: a simplified concept for management of hepatocellular drug-induced liver injury in patients with abnormal baseline liver tests | Full Text | References | PDF (1.1 MB) | EPUB

55 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Underuse of GLP-1 receptor agonists in the management of type 2 diabetes despite a favorable benefit-safety profile

André J. Scheen

Review Article | Published online: 13 May 2024

Comparison of safety of acetaminophen and ibuprofen in minors: based on the FAERS database

Jing Wang et al.

Article | Published online: 12 May 2024

A real-world disproportionality analysis of the FDA adverse event reporting system events for ibuprofen

Yikuan Du et al.

Article | Published online: 9 May 2024

Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment

Giacomo Caldarola et al.

Article | Published online: 8 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.23, Iss.4, 2024)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?